ASK8 Antibody

Shipped with Ice Packs
In Stock

Description

ASKB589: Anti-Claudin Monoclonal Antibody

ASKB589 is a humanized IgG1 monoclonal antibody targeting Claudin 18.2 (CLDN18.2), a transmembrane protein overexpressed in gastric/gastroesophageal junction (G/GEJ) cancers and pancreatic cancers . Its mechanism includes antibody-dependent cellular cytotoxicity (ADCC) enhancement, designed to improve tumor-targeting efficacy.

Key Features

PropertyDetail
TargetClaudin 18.2 (CLDN18.2)
IsotypeIgG1
Development StagePhase III pivotal trial (China) for G/GEJ cancer
Combination TherapiesCAPOX chemotherapy, PD-1 inhibitors (e.g., pembrolizumab)
Safety ProfileNo dose-limiting toxicity (DLT) observed up to 20 mg/kg monotherapy
Diagnostic CompanionCLDN18.2 immunohistochemistry (IHC) kit for patient stratification

Phase I/II Study (NCT04632108)

  • Design: Dose escalation (0.3–20 mg/kg monotherapy; 3–15 mg/kg + chemotherapy) .

  • Population: Advanced solid tumors (Part A); G/GEJ cancers (Part B).

  • Results:

    • Safety: No maximum tolerated dose (MTD) identified; well-tolerated up to 20 mg/kg .

    • Efficacy: Preliminary antitumor activity observed in CLDN18.2-positive tumors .

Phase III Program

  • Focus: First-line G/GEJ cancer with PD-1 inhibitor + chemotherapy .

  • Companion Diagnostic: High-sensitivity IHC kit for CLDN18.2 expression .

Mechanistic Advantages of ASKB589

  • ADCC Enhancement: Engineered to boost innate immune response via Fcγ receptor engagement .

  • Bispecific Potential: Synergizes with PD-1 inhibitors to enhance adaptive immunity .

  • Broad Applicability: Targets multiple CLDN18.2-expressing cancers (e.g., pancreatic) .

Comparative Analysis with Other Antibodies

AntibodyTargetIndicationDevelopment Stage
ASKB589CLDN18.2G/GEJ, pancreatic cancerPhase III (China)
10E8.4/iMab (bispecific)HIV gp41/CD4HIV prophylaxisPhase I (RV584)
AnxA8 IgGAnnexin A8Antiphospholipid syndromePreclinical

Research Gaps and Limitations

  • ASK8 Antibody: No publications or trials match this nomenclature. The closest candidate is ASKB589.

  • AnxA8 Antibodies: While unrelated to ASK8, AnxA8 IgG antibodies are under investigation as biomarkers for antiphospholipid syndrome (APS) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ASK8 antibody; At3g21830 antibody; MSD21.20SKP1-like protein 8 antibody; AtSK8 antibody
Target Names
ASK8
Uniprot No.

Target Background

Function
ASK8 Antibody is involved in the ubiquitination and subsequent proteasomal degradation of target proteins. It forms a SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complex in conjunction with CUL1, RBX1, and an F-box protein. The functional specificity of this complex is determined by the specific F-box protein involved. Within the SCF complex, ASK8 functions as an adapter, connecting the F-box protein to CUL1.
Database Links

KEGG: ath:AT3G21830

STRING: 3702.AT3G21830.1

UniGene: At.62404

Protein Families
SKP1 family
Subcellular Location
Nucleus.
Tissue Specificity
Restricted to siliques.

Q&A

What is the ASK8 antibody and what is its target protein?

ASK8 antibody is a polyclonal antibody raised in rabbits against recombinant Arabidopsis thaliana ASK8 protein. The target protein, ASK8, is part of the SKP1-like protein family in Arabidopsis thaliana, which plays critical roles in protein ubiquitination and degradation pathways through SCF (Skp-Cullin-F-box) complexes . This antibody allows researchers to detect and study ASK8 protein expression and function in plant molecular biology research. It's important to note that ASK8 should not be confused with Annexin A8 (ANXA8), which is a human protein with distinct antibodies developed for its detection .

What are the validated applications for ASK8 antibody?

The ASK8 antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications . These techniques allow researchers to detect and quantify ASK8 protein in various experimental contexts. When using this antibody for Western blotting, researchers typically observe a specific band corresponding to the molecular weight of ASK8. The antibody has been affinity-purified to enhance specificity for its target protein, making it suitable for these applications in research contexts focusing on Arabidopsis thaliana proteins .

What are the optimal storage conditions for ASK8 antibody?

ASK8 antibody should be stored at -20°C or -80°C upon receipt to maintain its stability and immunoreactivity . It's provided in liquid form in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . Researchers should avoid repeated freeze-thaw cycles as this can lead to denaturation of the antibody and loss of binding activity. For working solutions, aliquoting the antibody into smaller volumes before freezing is recommended to minimize freeze-thaw cycles. When handled properly, the antibody can maintain its activity for the duration of typical research projects.

How can ASK8 antibody be used to study SCF complex formation and function in plants?

ASK8 antibody can be employed in co-immunoprecipitation (co-IP) experiments to investigate protein-protein interactions within SCF complexes. By using the ASK8 antibody to pull down ASK8 protein from plant cell lysates, researchers can identify associated proteins through subsequent Western blotting or mass spectrometry analysis. This approach allows for the characterization of novel interactions between ASK8 and other components of the ubiquitination machinery.

For studying the dynamics of SCF complex formation, researchers can combine immunoprecipitation with ASK8 antibody followed by in vitro ubiquitination assays to assess the functional consequences of these interactions. Additionally, chromatin immunoprecipitation (ChIP) using ASK8 antibody may reveal associations between SCF complexes and specific genomic regions, providing insights into the regulatory functions of ASK8-containing complexes. These advanced applications extend beyond simple protein detection to uncover mechanistic details of ASK8 function in plant cellular processes .

What methodological considerations should be taken into account when performing immunohistochemistry with ASK8 antibody?

While immunohistochemistry (IHC) is not specifically listed among the validated applications for the ASK8 antibody , researchers interested in adapting it for IHC should first validate its performance in this context. Drawing from protocols used with other plant antibodies and similar approaches used with antibodies like anti-ANXA8 , several methodological considerations are important:

  • Tissue fixation: Plant tissues should be appropriately fixed (typically with paraformaldehyde) to preserve protein structure while maintaining accessibility to antibody binding.

  • Antigen retrieval: Heat-induced epitope retrieval may be necessary to expose the ASK8 epitope in fixed tissues, similar to the approach used for ANXA8 detection in human tissues .

  • Blocking optimization: Plant tissues contain many endogenous enzymes that can cause background staining. Optimizing blocking solutions is crucial for reducing non-specific binding.

  • Antibody dilution: A titration experiment should be performed to determine the optimal antibody concentration that yields specific staining with minimal background.

  • Detection system: Selection of an appropriate secondary antibody and visualization method (fluorescent or chromogenic) should be based on the experimental objectives and available imaging equipment.

Pilot experiments with positive and negative controls are essential before applying this technique to experimental samples.

How can researchers effectively distinguish between specific and non-specific binding when using ASK8 antibody?

Distinguishing between specific and non-specific binding is critical for accurate interpretation of results with ASK8 antibody. Researchers should implement multiple controls and validation strategies:

  • Negative controls: Include samples from ASK8 knockout plants or use pre-immune serum at the same concentration as the primary antibody to assess background signal levels.

  • Peptide competition assays: Pre-incubate the ASK8 antibody with excess recombinant ASK8 protein or immunizing peptide before application to the sample. Specific binding should be significantly reduced or eliminated.

  • Signal correlation with expression levels: Compare antibody signal across samples with known differences in ASK8 expression (e.g., following treatments that up- or down-regulate ASK8).

  • Multiple detection methods: Confirm findings using complementary techniques, such as correlating Western blot results with qPCR data on ASK8 transcript levels.

  • Positive controls: Include samples with known ASK8 expression as reference points for evaluating signal specificity.

By implementing these strategies, researchers can confidently attribute observed signals to genuine ASK8 detection rather than artifacts or cross-reactivity with other proteins .

What is the optimal protocol for using ASK8 antibody in Western blotting?

When using ASK8 antibody for Western blotting, researchers should follow this optimized protocol based on general antibody principles and specific considerations for plant proteins:

  • Sample preparation: Extract total protein from Arabidopsis tissues using an appropriate buffer containing protease inhibitors. Quantify protein concentration using Bradford or BCA assay.

  • SDS-PAGE: Separate 20-40 μg of protein per lane on a 10-12% polyacrylamide gel. Include molecular weight markers to identify the ASK8 band.

  • Transfer: Transfer proteins to a PVDF membrane using standard wet transfer protocols (similar to those used for ANXA8 detection ).

  • Blocking: Block the membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.

  • Primary antibody incubation: Dilute ASK8 antibody (optimal dilution should be determined empirically, typically starting at 1:1000) in blocking buffer and incubate overnight at 4°C.

  • Washing: Wash the membrane 3-4 times with TBST, 5-10 minutes each.

  • Secondary antibody: Incubate with an appropriate HRP-conjugated secondary antibody (anti-rabbit IgG) at a dilution of 1:5000-1:10000 for 1 hour at room temperature.

  • Detection: After washing, visualize using enhanced chemiluminescence (ECL) reagent and appropriate imaging system.

For optimal results, researchers should include positive controls and perform preliminary experiments to determine the ideal antibody concentration for their specific samples and experimental conditions .

How should researchers optimize ELISA protocols for ASK8 antibody?

Optimizing ELISA protocols for ASK8 antibody requires careful consideration of several parameters:

  • Coating conditions: For direct ELISA, coat plates with 1-5 μg/ml of purified ASK8 protein or 10-50 μg/ml of total plant extract in carbonate-bicarbonate buffer (pH 9.6) overnight at 4°C.

  • Blocking: Block with 1-3% BSA or 5% non-fat dry milk in PBS for 1-2 hours at room temperature to prevent non-specific binding.

  • Antibody dilution: Prepare a dilution series of ASK8 antibody (1:500 to 1:10,000) to determine the optimal concentration that provides the best signal-to-noise ratio.

  • Incubation conditions: Incubate with primary antibody for 1-2 hours at room temperature or overnight at 4°C, then with an appropriate secondary antibody (typically HRP-conjugated anti-rabbit IgG) for 1 hour at room temperature.

  • Substrate selection: Choose an appropriate substrate for signal development based on the required sensitivity (TMB, ABTS, or OPD).

  • Controls: Include negative controls (wells without primary antibody or with pre-immune serum) and positive controls (if available) to validate the specificity of detection.

  • Data analysis: Generate standard curves if quantitative measurements are needed, and ensure that signals fall within the linear range of detection.

For sandwich ELISA applications, researchers would need to obtain or develop a capture antibody that recognizes a different epitope of ASK8 than the detection antibody .

What cross-reactivity concerns should researchers be aware of when using ASK8 antibody?

Researchers should be vigilant about potential cross-reactivity when using ASK8 antibody, particularly given the existence of multiple SKP1-like proteins in Arabidopsis thaliana:

  • Homologous proteins: The Arabidopsis genome contains approximately 21 SKP1-like (ASK) genes with varying degrees of sequence similarity. Researchers should verify the antibody's specificity against other ASK family members, particularly those with high sequence homology to ASK8.

  • Cross-species reactivity: While the ASK8 antibody is raised against and designed for Arabidopsis thaliana proteins , researchers working with related plant species should perform validation experiments to confirm cross-reactivity or lack thereof.

  • Validation approaches:

    • Compare signal patterns in wild-type versus ask8 mutant plants

    • Perform peptide competition assays with specific competitors

    • Use orthogonal methods (e.g., mass spectrometry) to confirm the identity of detected proteins

    • Test reactivity against recombinant proteins of closely related ASK family members

  • Experimental controls: Include appropriate controls in each experiment, such as samples known to express or lack ASK8, to help distinguish specific from non-specific signals.

By addressing these cross-reactivity concerns, researchers can increase confidence in their results and avoid misinterpretation of data due to antibody binding to non-target proteins .

How can researchers troubleshoot weak or absent signals when using ASK8 antibody?

When faced with weak or absent signals using ASK8 antibody, researchers should systematically troubleshoot using this approach:

  • Sample preparation issues:

    • Ensure complete protein extraction with fresh protease inhibitors

    • Verify protein concentration and integrity by Coomassie staining

    • Check for protein degradation by examining housekeeping proteins

  • Antibody-related factors:

    • Verify antibody activity has not been compromised by improper storage or repeated freeze-thaw cycles

    • Optimize antibody concentration (try higher concentrations if signal is weak)

    • Extend incubation time (overnight at 4°C rather than 1-2 hours at room temperature)

  • Detection system optimization:

    • Use a more sensitive detection reagent (enhanced ECL for Western blots)

    • Increase exposure time during imaging

    • For ELISA, try a more sensitive substrate or increase substrate development time

  • Technical considerations:

    • Ensure efficient protein transfer in Western blots (confirm with reversible staining)

    • Optimize blocking conditions to improve signal-to-noise ratio

    • Consider different membrane types (PVDF vs. nitrocellulose) for Western blotting

  • Biological factors:

    • Confirm ASK8 expression levels in your experimental conditions (some treatments or developmental stages may have naturally low expression)

    • Consider using a positive control sample known to express ASK8 at detectable levels

If these approaches fail to resolve the issue, researchers might need to consider whether their experimental conditions are appropriate for ASK8 detection or if alternative antibodies or detection methods should be explored .

What are the best practices for quantifying ASK8 expression using Western blot data?

Quantifying ASK8 expression from Western blot data requires rigorous methodology to ensure accuracy and reproducibility:

  • Experimental design:

    • Include biological replicates (minimum n=3) for statistical analysis

    • Load equal amounts of total protein per lane (validate with loading controls)

    • Include a dilution series of a reference sample to ensure measurements fall within the linear range of detection

  • Image acquisition:

    • Use a digital imaging system with a wide dynamic range

    • Avoid saturated pixels that would lead to underestimation of protein abundance

    • Capture images using consistent settings across all blots in a study

  • Normalization strategy:

    • Use appropriate loading controls (housekeeping proteins like actin or GAPDH)

    • Verify that loading controls are not affected by experimental treatments

    • Consider total protein normalization as an alternative to single protein loading controls

  • Quantification method:

    • Use densitometry software to measure band intensities

    • Define consistent regions of interest for all samples

    • Subtract background signal from adjacent areas on the blot

  • Data analysis:

    • Express ASK8 levels relative to loading controls or total protein

    • Apply appropriate statistical tests based on experimental design

    • Present data with measures of variability (standard deviation or standard error)

  • Validation:

    • Confirm trends with complementary techniques (qPCR, ELISA)

    • Ensure biological plausibility of observed changes

How can researchers integrate ASK8 antibody data with other -omics approaches for comprehensive analysis?

Integrating ASK8 antibody-derived data with other -omics approaches provides a more comprehensive understanding of ASK8 function in biological systems:

  • Transcriptomics integration:

    • Compare ASK8 protein levels (Western blot/ELISA) with mRNA expression (RNA-seq/qPCR)

    • Identify potential post-transcriptional regulation mechanisms when protein and mRNA levels diverge

    • Use transcriptome data to identify co-regulated genes that may function in common pathways with ASK8

  • Proteomics approaches:

    • Combine immunoprecipitation using ASK8 antibody with mass spectrometry to identify interaction partners

    • Compare changes in ASK8 levels with broader proteomic alterations during developmental processes or stress responses

    • Use proteomics to identify post-translational modifications of ASK8 that may regulate its function

  • Functional genomics integration:

    • Correlate ASK8 protein levels with phenotypic data from ask8 mutants or overexpression lines

    • Map ASK8-associated phenotypes to specific cellular pathways using genetic interaction studies

    • Use CRISPR-Cas9 engineered variants to validate functional implications of ASK8 interactions

  • Computational analysis:

    • Apply network analysis to position ASK8 within relevant protein interaction networks

    • Develop predictive models incorporating ASK8 expression data and functional outcomes

    • Use machine learning approaches to identify patterns across multiple data types

  • Visualization and data sharing:

    • Utilize interactive visualization tools to present integrated datasets

    • Deposit standardized data in appropriate repositories for community access

    • Adopt consistent metadata annotation to facilitate cross-study comparisons

By integrating multiple data types, researchers can move beyond descriptive studies to develop mechanistic understanding of ASK8's role in plant biology and potentially identify novel applications for ASK8-targeted interventions in agricultural biotechnology .

How can researchers design experiments to study the dynamic regulation of ASK8 in response to environmental stressors?

Designing robust experiments to study ASK8 regulation under environmental stress requires careful planning:

  • Stress treatment design:

    • Apply well-defined, reproducible stress conditions (drought, salt, temperature, pathogens)

    • Include appropriate controls (unstressed, mock treatments)

    • Implement time-course sampling to capture dynamic responses

    • Consider dose-response experiments to determine threshold effects

  • Comprehensive analysis of ASK8:

    • Monitor protein levels using the ASK8 antibody in Western blots at multiple timepoints

    • Track transcript levels using qRT-PCR or RNA-seq in parallel

    • Assess protein localization changes using cellular fractionation followed by immunoblotting

    • Examine post-translational modifications using immunoprecipitation and mass spectrometry

  • Functional correlations:

    • Link changes in ASK8 levels/states to physiological parameters

    • Monitor ubiquitination activity of SCF complexes containing ASK8

    • Identify and quantify substrates of ASK8-containing complexes under stress

  • Genetic approach integration:

    • Compare wild-type responses with ask8 mutants

    • Include complementation lines to confirm phenotype specificity

    • Consider conditional expression systems to manipulate ASK8 levels during specific stress phases

  • Data analysis framework:

    • Apply multivariate statistics to identify significant patterns

    • Use clustering analysis to group stress responses

    • Implement systems biology approaches to model ASK8 behavior within regulatory networks

This experimental framework allows researchers to comprehensively characterize how ASK8 contributes to plant stress responses, potentially revealing therapeutic targets for improving crop resilience to environmental challenges.

What considerations should be taken into account when using ASK8 antibody in chromatin immunoprecipitation (ChIP) experiments?

While ChIP is not among the validated applications for the ASK8 antibody , researchers interested in adapting it for this purpose should consider these critical factors:

  • Antibody suitability assessment:

    • Verify antibody specificity using Western blot of nuclear extracts

    • Perform preliminary immunoprecipitation experiments to confirm the antibody can pull down ASK8 under native conditions

    • Consider using epitope-tagged ASK8 constructs with validated tag antibodies as an alternative approach

  • Chromatin preparation optimization:

    • Determine optimal crosslinking conditions for plant tissues (formaldehyde concentration and time)

    • Optimize sonication parameters to generate DNA fragments of appropriate size (200-500 bp)

    • Ensure complete nuclei isolation and chromatin solubilization

  • Experimental controls:

    • Include input chromatin samples as normalization controls

    • Use IgG or pre-immune serum as negative controls for non-specific binding

    • Include positive controls targeting known DNA-binding proteins (e.g., histones)

    • Consider including ask8 mutant plants as biological negative controls

  • Protocol adaptations:

    • Adjust antibody concentrations and incubation conditions empirically

    • Modify washing stringency to balance specificity and yield

    • Consider dual crosslinking approaches if protein-protein interactions are being studied

  • Data validation:

    • Confirm enrichment of target regions by qPCR before proceeding to genome-wide analysis

    • Validate ChIP-seq peaks with independent ChIP-qPCR experiments

    • Correlate binding sites with transcriptional outcomes using RNA-seq

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.